In cancers of various organs (breast, liver, kidney, etc.), FBP1 is a putative tumor suppressor, negatively regulating aerobic glycolysis, reducing the Warburg effect and/or antagonizing the function of HIF. Here, FBP1 is linked to neoplasm.